Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc.’s (NASDAQ: ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously as a medical device. Both of these in vitro diagnostic (IVD)-ready solutions are available to customers and third-party developers to create diagnostic solutions using the technology.... Read more